315 related articles for article (PubMed ID: 11014642)
1. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE
Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642
[TBL] [Abstract][Full Text] [Related]
2. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
4. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
White NB; Greenstein SM; Cantafio AW; Schechner R; Glicklich D; McDonough P; Pullman J; Mohandas K; Boctor F; Uehlinger J; Tellis V
Transplantation; 2004 Sep; 78(5):772-4. PubMed ID: 15371687
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
[TBL] [Abstract][Full Text] [Related]
6. Early and late humoral rejection: a clinicopathologic entity in two times.
Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
Lehrich RW; Rocha PN; Reinsmoen N; Greenberg A; Butterly DW; Howell DN; Smith SR
Hum Immunol; 2005 Apr; 66(4):350-8. PubMed ID: 15866697
[TBL] [Abstract][Full Text] [Related]
8. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
[TBL] [Abstract][Full Text] [Related]
10. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
11. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin.
Shah A; Nadasdy T; Arend L; Brennan J; Leong N; Coppage M; Orloff M; Demme R; Zand MS
Transplantation; 2004 May; 77(9):1399-405. PubMed ID: 15167598
[TBL] [Abstract][Full Text] [Related]
12. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
Shimizu T; Tokiwa M; Yamaguchi Y
Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
[TBL] [Abstract][Full Text] [Related]
13. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
14. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies.
Akalin E; Dinavahi R; Friedlander R; Ames S; de Boccardo G; Sehgal V; Schröppel B; Bhaskaran M; Lerner S; Fotino M; Murphy B; Bromberg JS
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1160-7. PubMed ID: 18337549
[TBL] [Abstract][Full Text] [Related]
15. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
[TBL] [Abstract][Full Text] [Related]
16. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants.
Schweitzer EJ; Wilson JS; Fernandez-Vina M; Fox M; Gutierrez M; Wiland A; Hunter J; Farney A; Philosophe B; Colonna J; Jarrell BE; Bartlett ST
Transplantation; 2000 Nov; 70(10):1531-6. PubMed ID: 11118102
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients.
Lee KW; Park JB; Cho CW; Lee N; Yoo H; Kim K; Park H; Kang ES; Huh W; Kim S
Ann Transplant; 2017 Mar; 22():166-176. PubMed ID: 28348361
[TBL] [Abstract][Full Text] [Related]
18. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.
Crespo M; Pascual M; Tolkoff-Rubin N; Mauiyyedi S; Collins AB; Fitzpatrick D; Farrell ML; Williams WW; Delmonico FL; Cosimi AB; Colvin RB; Saidman SL
Transplantation; 2001 Mar; 71(5):652-8. PubMed ID: 11292296
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.
Lefaucheur C; Nochy D; Andrade J; Verine J; Gautreau C; Charron D; Hill GS; Glotz D; Suberbielle-Boissel C
Am J Transplant; 2009 May; 9(5):1099-107. PubMed ID: 19422335
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.
Rocha PN; Butterly DW; Greenberg A; Reddan DN; Tuttle-Newhall J; Collins BH; Kuo PC; Reinsmoen N; Fields T; Howell DN; Smith SR
Transplantation; 2003 May; 75(9):1490-5. PubMed ID: 12792502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
